Marked improvements in inflammatory cell infiltrates and decreased inflammatory mediator content (RANTES and COX-2) are seen after HSV-ENK treatment in two additional animal models in use in our laboratory (CFA arthritis and acute pancreatitis [21]). The gene discussed is CCL5; the disease is acute pancreatitis.